Market Place
Sourcing Support
FDA approvals slump 19% in H1 2024; NASH, COPD, PAH get new treatment options
The first half of 2024 saw a significant slowdown in approvals of new drugs and biologics by the US
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
Amsterdam to host EMA; China pulls Skype out of app stores
This week in Phispers, we tell you how Amsterdam became EU’s choice for hosting the EMA. As Bi
Pfizer sues J&J; Generics under pressure; China’s Fosun resurrects deal to buyout India’s Gland
This week, Phispers brings you news on how a federal judge in the US revoked ‘pharma bro&rsquo
Trump tells FDA to fund itself fully through industry fees; Astra’s CEO dumps Teva offer
This
week, Phispers brings you lots of regulatory news from the US, where the Trump
administration h
Did Abbott’s sales rep kill himself due to work pressure? Clinton’s VP nominee under scrutiny for receiving favors from Teva’s Barr
This week, Phispers brings you the latest on controversies, such as the one surrounding Hillary Clin
Top drugs by sales revenue in 2015: Who sold the biggest blockbuster drugs?
The year 2015 has gone down
in history as a record year for mergers and acquisitions in the pharmace
